477 related articles for article (PubMed ID: 28074521)
1. Assessment of the effectiveness of topical propranolol 4% gel for infantile hemangiomas.
Mashiah J; Kutz A; Rabia SH; Ilan EB; Goldberg I; Sprecher E; Harel A
Int J Dermatol; 2017 Feb; 56(2):148-153. PubMed ID: 28074521
[TBL] [Abstract][Full Text] [Related]
2. Enhanced Percutaneous Delivery of Beta-Blockers Using Thermal Resurfacing Drug Delivery System for Topical Treatment of Infantile Hemangiomas.
Mashiah J; Bar-Ilan E; Koren A; Friedman O; Zur E; Artzi O
Dermatology; 2020; 236(6):565-570. PubMed ID: 32653885
[TBL] [Abstract][Full Text] [Related]
3. Local administration of β-blockers for infantile hemangiomas: a systematic review and meta-analysis.
Ovadia SA; Landy DC; Cohen ER; Yang EY; Thaller SR
Ann Plast Surg; 2015 Feb; 74(2):256-62. PubMed ID: 25590249
[TBL] [Abstract][Full Text] [Related]
4. Review of topical beta blockers as treatment for infantile hemangiomas.
Painter SL; Hildebrand GD
Surv Ophthalmol; 2016; 61(1):51-8. PubMed ID: 26408055
[TBL] [Abstract][Full Text] [Related]
5. Effect of topical propranolol gel on plasma renin, angiotensin II and vascular endothelial growth factor in superficial infantile hemangiomas.
Tang YJ; Zhang ZZ; Chen SQ; Chen SM; Li CJ; Chen JW; Yuan B; Xia Y; Wang L
J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):759-762. PubMed ID: 26489635
[TBL] [Abstract][Full Text] [Related]
6. Topical propranolol for treatment of superficial infantile hemangiomas.
Xu G; Lv R; Zhao Z; Huo R
J Am Acad Dermatol; 2012 Dec; 67(6):1210-3. PubMed ID: 22516113
[TBL] [Abstract][Full Text] [Related]
7. Experience with Holter monitoring during propranolol therapy for infantile hemangiomas.
Jacks SK; Kertesz NJ; Witman PM; Fernandez Faith E
J Am Acad Dermatol; 2015 Aug; 73(2):255-7. PubMed ID: 26054433
[TBL] [Abstract][Full Text] [Related]
8. Infantile hemangioma: treatment with short course systemic corticosteroid therapy as an alternative for propranolol.
Nieuwenhuis K; de Laat PC; Janmohamed SR; Madern GC; Oranje AP
Pediatr Dermatol; 2013; 30(1):64-70. PubMed ID: 22958179
[TBL] [Abstract][Full Text] [Related]
9. Propranolol in the management of infantile hemangiomas: clinical response and predictors.
Balma-Mena A; Chakkittakandiyil A; Weinstein M; Lansang P; Ho N; Cammisuli S; Pope E
J Cutan Med Surg; 2012; 16(3):169-73. PubMed ID: 22713439
[TBL] [Abstract][Full Text] [Related]
10. Ultrasonography as an objective tool for assessment of infantile hemangioma treatment with propranolol.
Rotter A; Samorano LP; de Oliveira Labinas GH; Alvarenga JG; Rivitti-Machado MC; Bouer M; Santos PC; Silvestre DA; de Oliveira ZN
Int J Dermatol; 2017 Feb; 56(2):190-194. PubMed ID: 27813086
[TBL] [Abstract][Full Text] [Related]
11. Outpatient use of oral propranolol and topical timolol for infantile hemangiomas: survey results and comparison with propranolol consensus statement guidelines.
Kumar MG; Coughlin C; Bayliss SJ
Pediatr Dermatol; 2015; 32(2):171-9. PubMed ID: 25556828
[TBL] [Abstract][Full Text] [Related]
12. Treatment of infantile capillary hemangioma of the eyelid with systemic propranolol.
Vassallo P; Forte R; Di Mezza A; Magli A
Am J Ophthalmol; 2013 Jan; 155(1):165-170.e2. PubMed ID: 22967870
[TBL] [Abstract][Full Text] [Related]
13. Treatment of problematic infantile hemangiomas with propranolol: a series of 40 cases and review of the literature.
Oksiuta M; Matuszczak E; Dębek W; Dzienis-Koronkiewicz E; Hermanowicz A; Tylicka M
Postepy Hig Med Dosw (Online); 2014 Sep; 68():1138-44. PubMed ID: 25228522
[TBL] [Abstract][Full Text] [Related]
14. Combined Oral and Topical Beta Blockers for the Treatment of Early Proliferative Superficial Periocular Infantile Capillary Hemangioma.
Marey HM; Elmazar HF; Mandour SS; Khairy HA
J Pediatr Ophthalmol Strabismus; 2018 Jan; 55(1):37-42. PubMed ID: 28991344
[TBL] [Abstract][Full Text] [Related]
15. Update on infantile hemangiomas.
Lee KC; Bercovitch L
Semin Perinatol; 2013 Feb; 37(1):49-58. PubMed ID: 23419763
[TBL] [Abstract][Full Text] [Related]
16. Intolerable side effects during propranolol therapy for infantile hemangioma: frequency, risk factors and management.
Ji Y; Chen S; Wang Q; Xiang B; Xu Z; Zhong L; Yang K; Lu G; Qiu L
Sci Rep; 2018 Mar; 8(1):4264. PubMed ID: 29523832
[TBL] [Abstract][Full Text] [Related]
17. Treatment with propranolol for infantile hemangiomas: single-center experience.
Turhan AB; Bör Ö; Özdemir ZC
J Cosmet Dermatol; 2016 Sep; 15(3):296-302. PubMed ID: 27061310
[TBL] [Abstract][Full Text] [Related]
18. [Effect of propranolol gel on infantile hemangiomas].
Zhai YN; Song HT; Chen SQ; Zhang MX; Li CJ; Xia Y; Wang L
Zhonghua Zheng Xing Wai Ke Za Zhi; 2013 Jan; 29(1):25-8. PubMed ID: 23600126
[TBL] [Abstract][Full Text] [Related]
19. Topical Timolol Maleate 0.5% for Infantile Hemangioma: Its Effectiveness Compared to Ultrapotent Topical Corticosteroids - A Single-Center Experience of 278 Cases.
Danarti R; Ariwibowo L; Radiono S; Budiyanto A
Dermatology; 2016; 232(5):566-571. PubMed ID: 27592104
[TBL] [Abstract][Full Text] [Related]
20. Recurrence of infantile hemangioma after termination of propranolol treatment.
Chang L; Ma G; Jin Y; Ye X; Qiu Y; Chen H; Yu W; Yang X; Hu X; Lin X
Ann Plast Surg; 2014 Feb; 72(2):173-5. PubMed ID: 24406852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
